TABLE 1.
Dosing regimen (no. of rabbits)b | Lesion score (lesions/lobe) | Lung wt (g) | Fungal burden [log (CFU/g)] | No. (%) of rabbits with culture-positive BAL fluid |
---|---|---|---|---|
Untreated controls (9) | 4.33 ± 0.50 | 34.12 ± 4.00 | 1.87 ± 0.19 | 7 (78) |
AmB, 1 mg/kg (8) | 0.25 ± 0.25 c | 11.27 ± 0.42 c | 0.03 ± 0.03 c | 0 (0) e |
BMS, 50 mg/kg QD (6) | 0.83 ± 0.47 | 13.17 ± 1.70 | 0.83 ± 0.18 a,d,f | 1 (17) a |
BMS, 17 mg/kg TID (5) | 0.60 ± 0.40 | 11.32 ± 0.58 b | 0.51 ± 0.16 c | 2 (40) |
BMS, 150 mg/kg QD (6) | 0.33 ± 0.21 b | 13.02 ± 0.64 | 0.20 ± 0.11 c | 0 (0) b |
BMS, 50 mg/kg TID (6) | 0.33 ± 0.33 b | 12.00 ± 1.32 b | 0.25 ± 0.12 c | 0 (0) b |
All values are means ± SEM. Statistical significance: a, P < 0.05 versus untreated controls; b, P < 0.01 versus untreated controls; c, P < 0.001 versus untreated controls; d, P < 0.01 versus AmB-treated rabbits; e, P < 0.005 versus AmB-treated rabbits; f, P < 0.05 versus rabbits treated at 50 mg/kg TID and 150 mg/kg QD.
BMS, BMS 181184.